Hemolytic anemia associated with intravenous immunoglobulin in Kawasaki disease
Abstract Background The administration of high-dose intravenous immunoglobulin (IVIG) is a standard treatment for the management of Kawasaki disease (KD). IVIG is known to be a highly effective and safe treatment. Case presentation We report the development of hemolytic anemia in seven children rece...
Saved in:
Main Authors: | Eun Jung Cheon (Author), Jun Suk Oh (Author) |
---|---|
Format: | Book |
Published: |
BMC,
2024-01-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Hemolytic anemia following intravenous immunoglobulin therapy in patients treated for Kawasaki disease: a report of 4 cases
by: Berard Roberta, et al.
Published: (2012) -
A decision tree model for predicting intravenous immunoglobulin resistance and coronary artery involvement in Kawasaki disease
by: Jinwoon Joung, et al.
Published: (2022) -
A 2-month-old boy with hemolytic anemia and reticulocytopenia following intravenous immunoglobulin therapy for Kawasaki disease: a case report and literature review
by: Na Yeon Kim, et al.
Published: (2016) -
Intravenous Immunoglobulin Resistant Kawasaki Disease
by: Mohammad Reza Navaeifar, et al.
Published: (2013) -
Intravenous Immunoglobulin Resistant Kawasaki Disease
by: Mohammad Reza Navaeifar, et al.
Published: (2013)